EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
Holding EYPT?
Track your performance easily

EyePoint Pharmaceuticals (EYPT) Ownership - Who Owns EyePoint Pharmaceuticals?

816 Followers

EyePoint Pharmaceuticals (EYPT) Ownership Overview

13.26%13.78%0.45%8.65%63.85%
13.26% Insiders
0.45% Other Institutional Investors
8.65% ETFs
63.85% Public Companies and
Individual Investors
The ownership structure of EyePoint Pharmaceuticals (EYPT) stock is a mix of institutional, retail, and individual investors. Approximately 22.88% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 63.85% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 21, 2024
xxxxxxxxxxxxx
$19997
Aug 21, 2024
Goran Ando
Director
xxxxxxxxxxxxx
$39750
Aug 21, 2024
xxxxxxxxxxxxx
$99750
Aug 20, 2024
Nancy Lurker
Director
xxxxxxxxxxxxx
$25003

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,325,000Insider12.21%96,653,250
2,805,916Institution4.12%32,576,685
2,168,329Institution3.18%25,174,300
2,154,457Institution3.16%25,013,246
2,060,936Institution3.02%23,927,467
1,276,070Institution1.87%14,815,173
938,591Institution1.38%10,897,042
877,790Institution1.29%10,191,142
670,941Institution0.98%7,789,625
640,274Institution0.94%7,433,581

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,168,329Institution3.18%25,174,300
2,060,936Institution3.02%23,927,467
1,276,070Institution1.87%14,815,173
670,941Institution0.98%7,789,625
558,536Institution0.82%6,484,603
435,923Institution0.64%5,061,066
410,899Institution0.60%4,770,537
351,408Institution0.52%4,079,847
245,698Institution0.36%2,852,554
170,599Institution0.25%1,980,654

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,285,224Institution1.89%15,037,121
1,559,245Institution2.29%12,458,368
800,378Institution1.17%6,395,020
550,205Institution0.81%6,116,207
257,835Institution0.38%3,016,670
205,844Institution0.30%2,408,375
228,854Institution0.34%1,828,543
139,197Institution0.20%1,678,716
114,312Institution0.17%1,337,450
165,093Institution0.24%1,319,093

FAQ

Who Owns EyePoint Pharmaceuticals Inc (EYPT)?
According to the latest TipRanks data, approximately 0.45% of the company's stock is held by institutional investors, 13.26% is held by insiders, and 63.85% is held by retail investors.
    What percentage of EyePoint Pharmaceuticals Inc (EYPT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.45% of EyePoint Pharmaceuticals Inc (EYPT) stock is held by institutional investors.
      What percentage of EyePoint Pharmaceuticals Inc (EYPT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 63.85% of EyePoint Pharmaceuticals Inc (EYPT) stock is held by retail investors.
        Who owns the most shares of EyePoint Pharmaceuticals Inc (EYPT)?
        Cormorant Asset Management, LLC owns the most shares of EyePoint Pharmaceuticals Inc (EYPT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis